These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9316177)

  • 1. Decision-making about genetic testing among women at familial risk for breast cancer.
    Jacobsen PB; Valdimarsdottier HB; Brown KL; Offit K
    Psychosom Med; 1997; 59(5):459-66. PubMed ID: 9316177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
    Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
    Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
    Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
    Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes about genetic testing for breast-ovarian cancer susceptibility.
    Lerman C; Daly M; Masny A; Balshem A
    J Clin Oncol; 1994 Apr; 12(4):843-50. PubMed ID: 8151327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
    Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
    Benkendorf JL; Reutenauer JE; Hughes CA; Eads N; Willison J; Powers M; Lerman C
    Am J Med Genet; 1997 Dec; 73(3):296-303. PubMed ID: 9415688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
    Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
    J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
    Cappelli M; Surh L; Humphreys L; Verma S; Logan D; Hunter A; Allanson J
    Clin Genet; 1999 Jun; 55(6):419-30. PubMed ID: 10450858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
    Gwyn K; Vernon SW; Conoley PM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pros and cons of genetic testing for breast and ovarian cancer risk.
    Frank TS; Braverman AM
    Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?
    Geller G; Bernhardt BA; Doksum T; Helzlsouer KJ; Wilcox P; Holtzman NA
    J Clin Oncol; 1998 Aug; 16(8):2868-76. PubMed ID: 9704741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
    Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.